Related Experiment Video
Updated: Oct 25, 2025

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Coronavirus Disease 2019 in a Patient With a Systemic Autoinflammatory Syndrome due to an NLRC4 Inflammasomopathy
Jeffrey K Duncan-Lowey1,2, Vaidehi Chowdhary3, Dana W Dunne1
1Section of Infectious Diseases, Department of Medicine. Yale University School of Medicine, New Haven, Connecticut, USA.
Abstract:
The effect of autoinflammatory diseases on severe acute respiratory syndrome coronavirus 2 infection remains unknown. We report a case of coronavirus disease 2019 (COVID-19) in a patient with autoinflammation with infantile enterocolitis with inflammatory flares due to a mutation in the inflammasome component NLRC4. This case highlights the role of immunosuppression in patients with autoinflammation with COVID-19.
Insights
Autoinflammatory diseases
Area of Science:
- Immunology
- Infectious Diseases
- Genetics
Background:
- The impact of autoinflammatory diseases on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is not well understood.
- Autoinflammatory diseases involve dysregulation of the innate immune system, potentially affecting viral responses.
Purpose of the Study:
- To describe a case of coronavirus disease 2019 (COVID-19) in a patient with a specific autoinflammatory disease.
- To explore the implications of immunosuppression in managing COVID-19 in patients with autoinflammation.
Main Methods:
- Case report detailing a patient with autoinflammation with infantile enterocolitis.
- Genetic analysis identifying a mutation in the NLRC4 inflammasome component.
- Clinical observation of the patient's COVID-19 course.
Main Results:
- The patient presented with COVID-19.
- The patient had a history of autoinflammation with infantile enterocolitis due to an NLRC4 mutation.
- The case underscores the importance of considering immunosuppression in autoinflammatory patients with COVID-19.
Conclusions:
- This case highlights the complex interplay between autoinflammatory diseases, genetic mutations (NLRC4), and viral infections like COVID-19.
- Immunosuppressive therapies in autoinflammation may influence the clinical course and management of SARS-CoV-2 infection.
More Related Videos
06:52Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Nephrotic Syndrome I : Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammation
Nephrotic Syndrome II : Assessment and Medical Management
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...